Evidence map›Paper›PMID 32344717›Full record

ReviewCancers2020

Incidence of Occult Lymph Node Metastasis in Primary Larynx Squamous Cell Carcinoma, by Subsite, T Classification and Neck Level: A Systematic Review.

Alvaro Sanabria, Jatin P Shah, Jesus E Medina, Kerry D Olsen, K Thomas Robbins, Carl E Silver, Juan P Rodrigo, Carlos Suárez, Andrés Coca-Pelaz, Ashok R Shaha and 10 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Selective neck dissection of level IIB in cN0 laryngeal cancer: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Pooled it
  4. Quantitative analysis of midline involvement for predicting contralateral cervical lymph node metastasis in supraglottic and glottic squamous cell carcinoma.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  5. Review
  6. Factors associated with occult ipsilateral and contralateral nodal metastasis in resectable lateralized laryngeal and hypopharyngeal malignancies.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  7. The neck matters: optimising lymph node management in laryngeal cancer.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026
    Review
  8. Is there a role for adjuvant radiotherapy after partial laryngectomy? A propensity score matched analysis.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026
    Observational
  9. Article
  10. Review
  11. Article
  12. Preoperative inflammatory ratios as predictors of occult nodal disease in supraglottic carcinoma: implications for transoral laser microsurgery planning.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  13. Article
  14. European Laryngological Society consensus statement on optimal monitoring schedules after treatment for early glottic cancer: a risk-stratification.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  15. Predictive Factors of Occult Lymph Node Involvement in Advanced Laryngeal Squamous Cell Carcinoma.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025
    Article
  16. Observational
  17. Review
  18. The relationship between depth of invasion and cervical lymph node metastasis in patients with laryngeal squamous cell carcinoma.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Observational
  19. Review
  20. Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 9 countries.

Alvaro SanabriaDepartment of Surgery, School of Medicine, Universidad de Antioquia/Hospital Universitario San Vicente Fundación, Medellín 050010, Colombia.
Jatin P ShahDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Jesus E MedinaDepartment of Otorhinolaryngology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Kerry D OlsenDepartment of Otorhinolaryngology, Mayo Clinic, Rochester, MN 55902, USA.
K Thomas RobbinsDepartment of Otolaryngology-Head and Neck Surgery, Southern Illinois University School of Medicine, Springfield, IL 32952, USA.
Carl E SilverDepartment of Surgery, University of Arizona College of Medicine, Phoenix, AZ 85259, USA.
Juan P RodrigoDepartment of Otolaryngology, Hospital Universitario Central de Asturias-ISPA, 33011 Oviedo, Spain.ORCID 0000-0003-3063-0890
Carlos SuárezInstituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain.
Andrés Coca-PelazDepartment of Otolaryngology, Hospital Universitario Central de Asturias-ISPA, 33011 Oviedo, Spain.
Ashok R ShahaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Antti A MäkitieDepartment of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, FI-00029 HUS Helsinki, Finland.ORCID 0000-0002-0451-2404
Alessandra RinaldoUniversity of Udine School of Medicine, 33100 Udine, Italy.
Remco de BreeDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.ORCID 0000-0001-7128-5814
Primož StrojanDepartment of Radiation Oncology, Institute of Oncology, SI-1000 Ljubljana, Slovenia.ORCID 0000-0002-0445-112X
Marc HamoirDepartment of Head and Neck Surgery, UC Louvain, St Luc University Hospital and King Albert II Cancer Institute, 1200 Brussels, Belgium.ORCID 0000-0001-8547-2768
Robert P TakesDepartment of Otolaryngology-Head and Neck Surgery, Radboud University Medical Center, 6500HB Nijmegen, The Netherlands.
Elisabeth V SjögrenDepartment of Otolaryngology-Head and Neck Surgery, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands.
Trinitia CannonDepartment of Head and Neck Surgery and Communication Sciences, Duke University Health System, Durham, NC 27609, USA.
Luiz P KowalskiDepartment of Otorhinolaryngology-Head and Neck Surgery, A.C. Camargo Cancer Center, 01509-900 São Paulo, Brazil.ORCID 0000-0002-0481-156X
Alfio FerlitoInternational Head and Neck Scientific Group, 35100 Padua, Italy.
Memorial Sloan Kettering Cancer Center · USUniversidad de Oviedo · ESCliniques Universitaires Saint-Luc · BEDuke University Health System · USHospital Universitario de San Vicente Fundación · COInstitute of Oncology Ljubljana · SIInstituto de Investigación Sanitaria del Principado de Asturias · ESLeiden University · NLMayo Clinic · USRadboud University Nijmegen · NLSouthern Illinois University School of Medicine · USUniversidade de São Paulo · BRUniversity Medical Center Utrecht · NLUniversity of Arizona · USUniversity of Helsinki · FIUniversity of Oklahoma Health Sciences Center · USUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLarynx cancer is a common site for tumors of the upper aerodigestive tract. In cases with a clinically negative neck, the indications for an elective neck treatment are still debated. The objective is to define the prevalence of occult metastasis based on the subsite of the primary tumor, T classification and neck node levels involved.

methodsAll studies included provided the rate of occult metastases in cN0 larynx squamous cell carcinoma patients. The main outcome was the incidence of occult metastasis. The pooled incidence was calculated with random effects analysis.

results36 studies with 3803 patients fulfilled the criteria. The incidence of lymph node metastases for supraglottic and glottic tumors was 19.9% (95% CI 16.4-23.4) and 8.0% (95% CI 2.7-13.3), respectively. The incidence of occult metastasis for level I, level IV and level V was 2.4% (95% CI 0-6.1%), 2.0% (95% CI 0.9-3.1) and 0.4% (95% CI 0-1.0%), respectively. For all tumors, the incidence for sublevel IIB was 0.5% (95% CI 0-1.3).

conclusionsThe incidence of occult lymph node metastasis is higher in supraglottic and T3-4 tumors. Level I and V and sublevel IIB should not be routinely included in the elective neck treatment of cN0 laryngeal cancer and, in addition, level IV should not be routinely included in cases of supraglottic tumors.

Indexed as

glottislarynx neoplasmneck dissectionsupraglottissystematic review

Identifiers

PMID32344717
PMCPMC7225965
OpenAlexW3019040682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.